Compare SUNB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUNB | DGX |
|---|---|---|
| Founded | 1947 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4B | 26.2B |
| IPO Year | 2025 | 1996 |
| Metric | SUNB | DGX |
|---|---|---|
| Price | $74.58 | $237.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 13 |
| Target Price | $70.75 | ★ $214.38 |
| AVG Volume (30 Days) | ★ 6.6M | 881.3K |
| Earning Date | 06-16-2026 | 04-21-2026 |
| Dividend Yield | 1.49% | ★ 1.82% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | 1.07 | ★ 5.08 |
| Revenue | ★ $11,154,000,000.00 | $11,035,000,000.00 |
| Revenue This Year | $4.31 | $7.53 |
| Revenue Next Year | $5.06 | $3.77 |
| P/E Ratio | $67.98 | ★ $46.54 |
| Revenue Growth | 3.36 | ★ 11.78 |
| 52 Week Low | $61.03 | $171.18 |
| 52 Week High | $86.68 | $248.84 |
| Indicator | SUNB | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 52.50 | 48.68 |
| Support Level | $74.41 | $230.43 |
| Resistance Level | $78.20 | $240.13 |
| Average True Range (ATR) | 2.80 | 5.51 |
| MACD | 0.44 | -1.05 |
| Stochastic Oscillator | 70.80 | 46.55 |
Sunbelt Rentals (formerly UK-based Ashtead Group) is the number two equipment rental company in the US (11% market share), with a smaller presence in Canada and the UK. Sunbelt operates a rental fleet of just over $15 billion across a network of 1,200 stores in the US, nearly CAD 2 billion of fleet and 135 stores in Canada, and GBP 1.1 billion and 190 stores in the UK. The company has experienced rapid growth over the past decade as its customers increasingly turn to rental versus owning equipment outright. The general tool business has been augmented by the Specialty Rental business, which has grown to 30% of the mix. Revenue is now greater than 50% nonconstruction, with the remainder focused more directly on commercial construction.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.